Crossmark

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12936-023-04530-5

Published Online: 2023-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lingani, Moussa http://orcid.org/0000-0002-5651-2035
Zango, Serge H.

Valéa, Innocent

Samadoulougou, Sékou

Somé, Georges

Sanou, Maïmouna

Kaboré, Berenger

Rouamba, Toussaint

Sorgho, Herman

Tahita, Marc C.

Derra, Karim

Dramaix, Michèle

Tinto, Halidou

Donnen, Philippe

Robert, Annie
License Information

Text and Data Mining valid from 2023-03-17

Version of Record valid from 2023-03-17
More Information

Article History

Received: 16 February 2023

Accepted: 13 March 2023

First Online: 17 March 2023

Declarations

:

: Ethical clearance was obtained from the national ethics committee of health, Burkina Faso (clearance certificate number 2018-7-096). All participants provided a written informed consent prior to their participation. All methods were performed in accordance with the relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below